Over 30% Of Covaxin Takers Report Adverse Effect, Claims BHU Study; Menstrual Abnormalities Seen In Women
The study, which was published in the journal Springer Nature, claimed around 50 per cent reportedly complained of infections during the follow-up period, which was dominated by viral upper respiratory tract infections.
May 17, 2024, 10:10 AM IST
The country's first Nasal Corona vaccine launches on Republic Day
Nasal Covid-19 Vaccine: The first intranasal Covid-19 vaccine 'Incovac' developed in the country will be started from January 26. It has been made by Swadeshi Bharat Biotech.
Jan 22, 2023, 10:32 AM IST
Nasal COVID Vaccine: Just 8 drops of needle-free booster dose can save you from twin fear of injection and infection!
Nasal Covid Vaccine Bharat Biotech India: Bharat Biotech's vaccine is set to revolutionize the way COVID vaccinations are delivered. The needle-free vaccine will be administered through nasal drops. But at the same time, it has been informed that those who have already taken the booster dose do not need to take a new vaccination.
Dec 29, 2022, 12:03 PM IST
Nationwide emergency mock drills from Tuesday - India's Covid response begins
According to the Union Health Ministry, an emergency response mock drill will be conducted at hospitals across the country from December 27 in view of a spike in Covid cases in some countries.
Dec 23, 2022, 11:43 AM IST
'Misleading, fallacious': Govt rubbishes media reports claiming Covaxin approval due to political pressure
The Central Drugs Standard Control Organization's Subject Expert Committee met on January 1 and 2, 2021 and made recommendations on Bharat Biotech's proposal for Restricted Emergency Approval of the COVID-19 virus vaccine
Nov 17, 2022, 14:48 PM IST
DCGI approves Corona's Nasal Vaccine
Another vaccine has been approved in the war against the corona epidemic. DCGI has approved Bharat Biotech's nasal vaccine for Corona. This will be the country's first nasal vaccine.
Sep 06, 2022, 16:54 PM IST
DCGI clears India’s FIRST Intranasal Covid-19 vaccine for restricted emergency use
The Hyderabad-based firm completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no side effect or adverse reaction reported so far, company sources had said.
Sep 06, 2022, 15:56 PM IST
Bharat Biotech completes clinical trials of India's first intranasal Covid vaccine, says 'it's safe'
Suchitra K Ella, Joint Managing Director, Bharat Biotech, said, "On this Independence Day, we are proud to announce the successful completion of clinical trials for BBV154 intranasal vaccine. If approved, the intranasal vaccine will make it easier to deploy in mass immunisation campaigns with an easy-to-administer formulation and delivery device.'
Aug 15, 2022, 17:54 PM IST
Bharat Biotech's Covid-19 nasal vaccine phase III trials completed
"If everything is okay, then we will get permission to launch and it will be the world's first clinically proven nasal Covid-19 vaccine", said Chairman and Managing Director of Bharat Biotech.
Jun 19, 2022, 07:01 AM IST
Germany clears Bharat Biotech’s Covaxin, no vaccination proof required for fliers from June 1
“Germany has approved Covaxin COVID19 vaccine. The entrants will no longer need proof of vaccination as the Federal Cabinet relaxes restrictions,” Bharat Biotech said on Twitter.
May 26, 2022, 13:59 PM IST
Covid-19 fourth wave: 'Single, variant-proof' vaccine coming soon! Check all details here
CEPI will fund the initiative under its USD 200 million programme to advance the development of vaccines that provide broad protection against SARS-Cov-2 variants and other betacoronaviruses.
May 10, 2022, 21:05 PM IST
Bharat Biotech seeks approval for Covaxin booster trials for 2-18 age group
Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of its Covid vaccine Covaxin for below 18 population.
May 05, 2022, 19:37 PM IST
Japan recognizes India's Covaxin to facilitate travel between both countries
Japan has recognised the Covid-19 vaccine COVAXIN by Bharat Biotech, for 1st and 2nd dose with effect from 10 April further ease the travel from India to Japan.
Apr 08, 2022, 16:56 PM IST
WHO's suspension of Bharat Biotech's Covaxin supply is only for UN agencies: Sources
The Hyderabad based Bharat Biotech`s anti-Covid Vaccine, Covaxin has been suspended by WHO under the Covax facility, announced the UN health body on Saturday, attributing it to deficiencies in manufacturing practices.
Apr 04, 2022, 16:09 PM IST
No impact on efficacy and safety of Covaxin, clarifies Bharat Biotech after WHO suspension
"The risk assessment to date does not indicate a change in the risk-benefit ratio. The data available to WHO, indicate the vaccine is effective and no safety concern exists," said Bharat Biotech.
Apr 04, 2022, 13:30 PM IST
WHO suspends UN supply of Bharat Biotech's Covaxin vaccine for Covid-19
The WHO said the Bharat Biotech vaccine is effective and no safety concerns exist, but the suspension of production for export will result in the interruption of Covaxin supply.
Apr 03, 2022, 12:26 PM IST
Bharat Biotech temporarily 'slows down' Covaxin production in India, check why
The vaccine maker, in a press release, said Bharat Biotech will focus on pending facility maintenance, process and facility optimisation activities for the coming period.
Apr 01, 2022, 22:42 PM IST
Would be a great achievement: AIIMS expert on nasal Covid vaccines
AIIMS senior epidemiologist Dr Sanjay Rai said that the vaccine would be a great achievement and could change the game for India’s fight against coronavirus.
Jan 31, 2022, 09:30 AM IST
BBV154, Bharat Biotech’s intranasal vaccine, gets DCGI’s approval for booster dose trials
The trials of Bharat Biotech's intranasal vaccine, BBV154, will take place at nine different sites across the country.
Jan 28, 2022, 15:55 PM IST
Covaxin booster shot neutralises Omicron, says Bharat Biotech
The study was conducted at the Emory Vaccine Center in Atlanta based on blood serum collected from 13 individuals, 28 days after their booster shot, the Bharat Biotech said.
Jan 12, 2022, 18:47 PM IST
